Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization

Current cancer nanomedicines can only mitigate adverse effects but fail to enhance therapeutic efficacies of anticancer drugs. Rational design of next-generation cancer nanomedicines should aim to enhance their therapeutic efficacies. Taking this into account, this review first analyzes the typical cancer-drug-delivery process of an intravenously administered nanomedicine and concludes that the delivery involves a five-step CAPIR cascade and that high efficiency at every step is critical to guarantee high overall therapeutic efficiency. Further analysis shows that the nanoproperties needed in each step for a nanomedicine to maximize its efficiency are different and even opposing in different steps, particularly what the authors call the PEG, surface-charge, size and stability dilemmas. To resolve those dilemmas in order to integrate all needed nanoproperties into one nanomedicine, stability, surface and size nanoproperty transitions (3S transitions for short) are proposed and the reported strategies to realize these transitions are comprehensively summarized. Examples of nanomedicines capable of the 3S transitions are discussed, as are future research directions to design high-performance cancer nanomedicines and their clinical translations.

[1]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[2]  Hideyoshi Harashima,et al.  A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. , 2011, Advanced drug delivery reviews.

[3]  N. Nishiyama,et al.  Charge-conversional polyionic complex micelles-efficient nanocarriers for protein delivery into cytoplasm. , 2009, Angewandte Chemie.

[4]  J. Feijen,et al.  Novel bioreducible poly(amido amine)s for highly efficient gene delivery. , 2007, Bioconjugate chemistry.

[5]  Efstathios Karathanasis,et al.  Is nanomedicine still promising? , 2011, Oncotarget.

[6]  X. Qi,et al.  Tumor-specific penetrating peptides-functionalized hyaluronic acid-d-α-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancers. , 2015, Biomaterials.

[7]  Kazunori Kataoka,et al.  A protein nanocarrier from charge-conversion polymer in response to endosomal pH. , 2007, Journal of the American Chemical Society.

[8]  Henrike Caysa,et al.  Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model. , 2011, ACS nano.

[9]  J. G. Solé,et al.  Nanoparticles for photothermal therapies. , 2014, Nanoscale.

[10]  Zhuxian Zhou,et al.  Degradable dual pH- and temperature-responsive photoluminescent dendrimers. , 2011, Chemistry.

[11]  U. Kompella,et al.  Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration , 2008, Molecular vision.

[12]  Christine Allen,et al.  The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. , 2010, Molecular pharmaceutics.

[13]  Yijia Zhang,et al.  Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release. , 2015, Biomaterials.

[14]  Marcelle Machluf,et al.  Reconstructed stem cell nanoghosts: a natural tumor targeting platform. , 2013, Nano letters.

[15]  R. Jain,et al.  Microvascular permeability of normal and neoplastic tissues. , 1986, Microvascular research.

[16]  Hiroshi Maeda,et al.  Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. , 2015, Advanced drug delivery reviews.

[17]  Jeffrey A Hubbell,et al.  PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. , 2007, Biomacromolecules.

[18]  Kam W. Leong,et al.  Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines , 2016 .

[19]  R. Rifkin,et al.  Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma , 2006, Cancer.

[20]  Wenjun Yang,et al.  Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost. , 2012, Journal of the American Chemical Society.

[21]  Y. Zhan,et al.  Multifunctioning pH‐responsive nanoparticles from hierarchical self‐assembly of polymer brush for cancer drug delivery , 2008 .

[22]  D. Thompson,et al.  Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[23]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[24]  Youqing Shen,et al.  Nuclear drug delivery for cancer chemotherapy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[25]  R. Schiffelers,et al.  Strategies for triggered drug release from tumor targeted liposomes , 2013, Expert opinion on drug delivery.

[26]  Jin-Zhi Du,et al.  Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. , 2011, Journal of the American Chemical Society.

[27]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[28]  A. Santoro,et al.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  Xin-guo Jiang,et al.  RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration. , 2014, Molecular pharmaceutics.

[30]  Jun Wang,et al.  Promoting tumor penetration of nanoparticles for cancer stem cell therapy by TGF-β signaling pathway inhibition. , 2016, Biomaterials.

[31]  W. Shao,et al.  Smart linkers in polymer–drug conjugates for tumor-targeted delivery , 2016, Journal of drug targeting.

[32]  Juan L. Vivero-Escoto,et al.  Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. , 2009, Journal of the American Chemical Society.

[33]  J. Kopeček,et al.  Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer. , 2015, Journal of the American Chemical Society.

[34]  Maohong Fan,et al.  Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery. , 2010, Nanomedicine.

[35]  Christine Allen,et al.  In Vivo Distribution of Polymeric Nanoparticles at the Whole-Body, Tumor, and Cellular Levels , 2010, Pharmaceutical Research.

[36]  M. Flessner,et al.  Resistance of Tumor Interstitial Pressure to the Penetration of Intraperitoneally Delivered Antibodies into Metastatic Ovarian Tumors , 2005, Clinical Cancer Research.

[37]  Mauro Ferrari,et al.  Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. , 2011, Accounts of chemical research.

[38]  T. Andresen,et al.  Drug delivery by an enzyme-mediated cyclization of a lipid prodrug with unique bilayer-formation properties. , 2009, Angewandte Chemie.

[39]  Lin Zhu,et al.  Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. , 2012, ACS nano.

[40]  Haiyan Chen,et al.  The targeted behavior of thermally responsive nanohydrogel evaluated by NIR system in mouse model. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[41]  T. Ji,et al.  An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic Cancer. , 2016, ACS applied materials & interfaces.

[42]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[43]  A. S. Sobolev,et al.  Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines , 2015, Theranostics.

[44]  Yuichi Yamasaki,et al.  Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. , 2004, Journal of the American Chemical Society.

[45]  P. Schumacker.  Reactive oxygen species in cancer: a dance with the devil. , 2015, Cancer cell.

[46]  Daniel W. Pack,et al.  Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.

[47]  Oliver Lieleg,et al.  Selective filtering of particles by the extracellular matrix: an electrostatic bandpass. , 2009, Biophysical journal.

[48]  R. Jain.  Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[49]  Younan Xia,et al.  A reactive oxygen species (ROS)-responsive polymer for safe, efficient, and targeted gene delivery in cancer cells. , 2013, Angewandte Chemie.

[50]  Yun Yen,et al.  CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing , 2016, Proceedings of the National Academy of Sciences.

[51]  Warren D. Foltz,et al.  MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. , 2011, Biomaterials.

[52]  Lichen Yin,et al.  Trigger-responsive, fast-degradable poly(β-amino ester)s for enhanced DNA unpackaging and reduced toxicity. , 2014, Biomaterials.

[53]  C. Murphy,et al.  Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles , 2016 .

[54]  Junxiao Ye,et al.  Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[55]  S. Thayumanavan,et al.  Redox-sensitive disassembly of amphiphilic copolymer based micelles. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[56]  K. Ulbrich,et al.  Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers. , 1998, Biochimica et biophysica acta.

[57]  Chih-Kuang Chen,et al.  Overcoming nonviral gene delivery barriers: perspective and future. , 2013, Molecular pharmaceutics.

[58]  Lei Xu,et al.  Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.

[59]  M. Flessner,et al.  Intraperitoneal Immunotherapy for Metastatic Ovarian Carcinoma: Resistance of Intratumoral Collagen to Antibody Penetration , 2006, Clinical Cancer Research.

[60]  Song Shen,et al.  Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery. , 2015, Journal of the American Chemical Society.

[61]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[62]  Didier Merlin,et al.  Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines. , 2010, Nature materials.

[63]  I. Oh,et al.  Paclitaxel-loaded polymeric micelle (230 mg/m(2)) and cisplatin (60 mg/m(2)) vs. paclitaxel (175 mg/m(2)) and cisplatin (60 mg/m(2)) in advanced non-small-cell lung cancer: a multicenter randomized phase IIB trial. , 2013, Clinical lung cancer.

[64]  Joseph C. Wu,et al.  Development of poly(β-amino ester)-based biodegradable nanoparticles for nonviral delivery of minicircle DNA. , 2013, ACS nano.

[65]  Ick Chan Kwon,et al.  Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[66]  Atsushi Harada,et al.  Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. , 2003, Angewandte Chemie.

[67]  Gert Storm,et al.  Sheddable Coatings for Long-Circulating Nanoparticles , 2007, Pharmaceutical Research.

[68]  D. Maysinger,et al.  Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles , 2003, Science.

[69]  M. Uesaka,et al.  Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.

[70]  Chunsheng Xiao,et al.  Emerging antitumor applications of extracellularly reengineered polymeric nanocarriers. , 2015, Biomaterials science.

[71]  Y. Bae,et al.  Biodegradable cationic nanoparticles loaded with an anticancer drug for deep penetration of heterogeneous tumours. , 2013, Biomaterials.

[72]  Daniel G. Anderson,et al.  Non-viral vectors for gene-based therapy , 2014, Nature Reviews Genetics.

[73]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[74]  Richard Hoogenboom,et al.  Poly(2-oxazoline)s: a polymer class with numerous potential applications. , 2009, Angewandte Chemie.

[75]  V. Torchilin,et al.  "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. , 2006, Bioconjugate chemistry.

[76]  W. Gradishar,et al.  Albumin-bound paclitaxel: a next-generation taxane , 2006, Expert opinion on pharmacotherapy.

[77]  M. Gottesman.  Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.

[78]  Sung Wan Kim,et al.  Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[79]  Mark E. Davis,et al.  Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle , 2013, Proceedings of the National Academy of Sciences.

[80]  Feng Liu,et al.  Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. , 2005, Advanced drug delivery reviews.

[81]  R. Langer,et al.  Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug Delivery , 2012, Journal of the American Chemical Society.

[82]  K. Toh,et al.  Analyzing spatiotemporal distribution of uniquely fluorescent nanoparticles in xenograft tumors. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[83]  Zhen Gu,et al.  ATP-triggered anticancer drug delivery , 2014, Nature Communications.

[84]  Shaoyi Jiang,et al.  Nanoparticles for drug delivery prepared from amphiphilic PLGA zwitterionic block copolymers with sharp contrast in polarity between two blocks. , 2010, Angewandte Chemie.

[85]  U. Bakowsky,et al.  Stabilized nanocarriers for plasmids based upon cross-linked poly(ethylene imine). , 2006, Biomacromolecules.

[86]  Juan L. Vivero-Escoto,et al.  Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery , 2010, Expert opinion on drug delivery.

[87]  Fabian Kiessling,et al.  Cancer nanomedicine: Is targeting our target? , 2016, Nature reviews. Materials.

[88]  Seiji Miura,et al.  Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[89]  S. Kannan,et al.  Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels. , 2008, Bioconjugate chemistry.

[90]  Vladimir P Torchilin,et al.  Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating. , 2002, International journal of pharmaceutics.

[91]  Anne L. van de Ven,et al.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.

[92]  Christopher E. Nelson,et al.  Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo. , 2013, ACS nano.

[93]  Jianbin Tang,et al.  The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment. , 2015, ACS nano.

[94]  Samir Mitragotri,et al.  Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects. , 2014, Nano today.

[95]  H. Maeda.  The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.

[96]  M. Michael,et al.  Tumoral drug metabolism: overview and its implications for cancer therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  C. Allen,et al.  Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[98]  Jin-Zhi Du,et al.  A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery. , 2010, Angewandte Chemie.

[99]  Robert J. Lee,et al.  A folate receptor-targeted liposomal formulation for paclitaxel. , 2006, International journal of pharmaceutics.

[100]  Z. Lu,et al.  Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[101]  Jun Wang,et al.  Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy , 2016, Proceedings of the National Academy of Sciences.

[102]  Vladimir P Torchilin,et al.  Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[103]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[104]  Ming-Zher Poh,et al.  Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions. , 2010, Biophysical journal.

[105]  Martin Donnelley,et al.  Challenges of up-scaling lentivirus production and processing. , 2016, Journal of biotechnology.

[106]  Peng Huang,et al.  Tumor-Specific Formation of Enzyme-Instructed Supramolecular Self-Assemblies as Cancer Theranostics. , 2015, ACS nano.

[107]  R. Agarwal,et al.  Ovarian cancer: strategies for overcoming resistance to chemotherapy , 2003, Nature Reviews Cancer.

[108]  Y. Zhan,et al.  Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles. , 2006, Biomacromolecules.

[109]  Dai Fukumura,et al.  Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize , 2007, Journal of cellular biochemistry.

[110]  Wim E Hennink,et al.  Circulation kinetics and biodistribution of dual-labeled polymersomes with modulated surface charge in tumor-bearing mice: comparison with stealth liposomes. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[111]  Mauro Ferrari,et al.  Multi-stage delivery nano-particle systems for therapeutic applications. , 2011, Biochimica et biophysica acta.

[112]  X. Yang,et al.  Programmed packaging of mesoporous silica nanocarriers for matrix metalloprotease 2-triggered tumor targeting and release. , 2015, Biomaterials.

[113]  Zhuxian Zhou,et al.  Esterase‐Activated Charge‐Reversal Polymer for Fibroblast‐Exempt Cancer Gene Therapy , 2016, Advanced materials.

[114]  Afsaneh Lavasanifar,et al.  Amphiphilic block copolymers for drug delivery. , 2003, Journal of pharmaceutical sciences.

[115]  R. Jain,et al.  Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages , 2015, PloS one.

[116]  Ruth Duncan,et al.  Polymer therapeutics: Top 10 selling pharmaceuticals - what next? , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[117]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[118]  You Han Bae,et al.  Super pH-sensitive multifunctional polymeric micelle. , 2005, Nano letters.

[119]  Zhuxian Zhou,et al.  A multifunctional PEG-PLL drug conjugate forming redox-responsive nanoparticles for intracellular drug delivery. , 2015, Journal of materials chemistry. B.

[120]  I. Papassotiriou,et al.  2017 Clinical trials update in new treatments of β‐thalassemia , 2016, American journal of hematology.

[121]  Leaf Huang,et al.  Pharmacokinetics and biodistribution of nanoparticles. , 2008, Molecular pharmaceutics.

[122]  K. Kataoka,et al.  pH-responsive oligodeoxynucleotide (ODN)-poly(ethylene glycol) conjugate through acid-labile beta-thiopropionate linkage: preparation and polyion complex micelle formation. , 2003, Biomacromolecules.

[123]  R K Jain,et al.  Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure. , 1989, Cancer research.

[124]  Anjie Dong,et al.  Synthesis of degradable functional poly(ethylene glycol) analogs as versatile drug delivery carriers. , 2007, Macromolecular bioscience.

[125]  S. Pun,et al.  HPMA-oligolysine copolymers for gene delivery: optimization of peptide length and polymer molecular weight. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[126]  Y. Zhan,et al.  Degradable poly(beta-amino ester) nanoparticles for cancer cytoplasmic drug delivery. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[127]  R K Jain,et al.  Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. , 1990, Cancer research.

[128]  Yaping Li,et al.  Long Circulation Red‐Blood‐Cell‐Mimetic Nanoparticles with Peptide‐Enhanced Tumor Penetration for Simultaneously Inhibiting Growth and Lung Metastasis of Breast Cancer , 2016, Advanced Functional Materials.

[129]  Jinming Hu,et al.  Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels. , 2012, Chemical Society reviews.

[130]  Daniel G. Anderson,et al.  Structure/property studies of polymeric gene delivery using a library of poly(β-amino esters). , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[131]  J. Benoit,et al.  The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. , 2010, Nanomedicine.

[132]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[133]  Yechezkel Barenholz,et al.  Pharmacokinetics of Pegylated Liposomal Doxorubicin , 2003, Clinical pharmacokinetics.

[134]  Xing-jie Liang,et al.  A Peptide‐Network Weaved Nanoplatform with Tumor Microenvironment Responsiveness and Deep Tissue Penetration Capability for Cancer Therapy , 2015, Advanced materials.

[135]  Erkki Ruoslahti,et al.  Transtumoral targeting enabled by a novel neuropilin-binding peptide , 2012, Oncogene.

[136]  Yuliang Zhao,et al.  Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer‐Associated Fibroblast Activation , 2015, Angewandte Chemie.

[137]  Yue Zhao,et al.  A new design for light-breakable polymer micelles. , 2005, Journal of the American Chemical Society.

[138]  Murali M. Yallapu,et al.  PEG-Functionalized Magnetic Nanoparticles for Drug Delivery and Magnetic Resonance Imaging Applications , 2010, Pharmaceutical Research.

[139]  Huile Gao,et al.  A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan. , 2016, Acta biomaterialia.

[140]  Scott E McNeil,et al.  Translational considerations for cancer nanomedicine. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[141]  K. Fujimori,et al.  Barrier ' ' Microscopic Tumor Nodules : Consequences of a ' ' Binding Site An Analysis of Monoclonal Antibody Distribution in Updated , 2006 .

[142]  S. Morimoto,et al.  Overcoming the polyethylene glycol dilemma via pathological environment-sensitive change of the surface property of nanoparticles for cellular entry. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[143]  J. Kopeček,et al.  HPMA copolymers: origins, early developments, present, and future. , 2010, Advanced drug delivery reviews.

[144]  Wei Liang,et al.  Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. , 2007, Journal of the National Cancer Institute.

[145]  Youqing Shen,et al.  Integration of Nanoassembly Functions for an Effective Delivery Cascade for Cancer Drugs , 2014, Advanced materials.

[146]  L. Pereira de Almeida,et al.  Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[147]  M. Radosz,et al.  Near-Critical Fluid Micellization for High and Efficient Drug Loading: Encapsulation of Paclitaxel into PEG-b-PCL Micelles , 2011 .

[148]  R. B. Campbell,et al.  Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors , 2004, Nature Medicine.

[149]  Zhuxian Zhou,et al.  Molecularly precise dendrimer-drug conjugates with tunable drug release for cancer therapy. , 2014, Angewandte Chemie.

[150]  A. Maitra,et al.  Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[151]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[152]  Chun Wang.  Bio-cluster nano-bomb for cancer drug delivery: efficacious fire at the target , 2015 .

[153]  Teri W. Odom,et al.  Controlling ligand density on nanoparticles as a means to enhance biological activity. , 2015, Nanomedicine.

[154]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[155]  J. Fréchet,et al.  Stimuli-responsive supramolecular assemblies of linear-dendritic copolymers. , 2004, Journal of the American Chemical Society.

[156]  Subra Suresh,et al.  Size‐Dependent Endocytosis of Nanoparticles , 2009, Advanced materials.

[157]  Andrea J. Hanson,et al.  Matrix metalloproteinase-assisted triggered release of liposomal contents. , 2008, Bioconjugate chemistry.

[158]  N. Van Rooijen,et al.  Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. , 1994, Biochimica et biophysica acta.

[159]  V. Torchilin,et al.  Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs. , 2014, Biomaterials.

[160]  Katharina Landfester,et al.  Interaction of nanoparticles with cells. , 2009, Biomacromolecules.

[161]  Xian‐Zheng Zhang,et al.  Dual-pH Sensitive Charge-Reversal Polypeptide Micelles for Tumor-Triggered Targeting Uptake and Nuclear Drug Delivery. , 2015, Small.

[162]  W. Hennink,et al.  Association and Dissociation Characteristics of Polymer/DNA Complexes Used for Gene Delivery , 1999, Pharmaceutical Research.

[163]  Dai Fukumura,et al.  Multistage nanoparticle delivery system for deep penetration into tumor tissue , 2011, Proceedings of the National Academy of Sciences.

[164]  F. Szoka,et al.  Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG--diortho ester--lipid conjugate. , 2001, Bioconjugate chemistry.

[165]  Juergen Siepmann,et al.  Modeling of diffusion controlled drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[166]  Ashutosh Chilkoti,et al.  Nanomaterials for Drug Delivery , 2012, Science.

[167]  J. F. Stoddart,et al.  Stimulated release of size-selected cargos in succession from mesoporous silica nanoparticles. , 2012, Angewandte Chemie.

[168]  P. Vasey,et al.  Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies , 2003, British Journal of Cancer.

[169]  Joseph W. Nichols,et al.  Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. , 2016, Nature nanotechnology.

[170]  Malar A. Azagarsamy,et al.  Guest-release control in enzyme-sensitive, amphiphilic-dendrimer-based nanoparticles through photochemical crosslinking. , 2011, Chemistry.

[171]  T. Porter,et al.  Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[172]  V. Torchilin,et al.  Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety , 2013, Proceedings of the National Academy of Sciences.

[173]  Jessie L.-S. Au,et al.  Drug Delivery and Transport to Solid Tumors , 2003, Pharmaceutical Research.

[174]  K. Pärn,et al.  PEG shielded MMP sensitive CPPs for efficient and tumor specific gene delivery in vivo. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[175]  M. Ogris,et al.  Acetal linked oligoethylenimines for use as pH-sensitive gene carriers. , 2008, Bioconjugate chemistry.

[176]  Baran D. Sumer,et al.  A Broad Nanoparticle-Based Strategy for Tumor Imaging by Nonlinear Amplification of Microenvironment Signals , 2013, Nature materials.

[177]  Cao Xie,et al.  International Journal of Pharmaceutics 9-nc-loaded Folate-conjugated Polymer Micelles as Tumor Targeted Drug Delivery System: Preparation and Evaluation in Vitro , 2022 .

[178]  Hong Yuan,et al.  Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy. , 2015, Molecular pharmaceutics.

[179]  M. Vallet‐Regí,et al.  Hybrid Collagenase Nanocapsules for Enhanced Nanocarrier Penetration in Tumoral Tissues. , 2015, ACS applied materials & interfaces.

[180]  Miriam Scadeng,et al.  Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.

[181]  Vladimir P Torchilin,et al.  Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. , 2008, Advanced drug delivery reviews.

[182]  Zhuxian Zhou,et al.  Fabrication of dendrimer-releasing lipidic nanoassembly for cancer drug delivery. , 2016, Biomaterials science.

[183]  J N Weinstein,et al.  A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[184]  R. Zhang,et al.  Indium-based and iodine-based labeling of HPMA copolymer-epirubicin conjugates: Impact of structure on the in vivo fate. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[185]  Kazunori Kataoka,et al.  Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. , 2005, Journal of the American Chemical Society.

[186]  Peisheng Xu,et al.  Redox Potential Ultrasensitive Nanoparticle for the Targeted Delivery of Camptothecin to HER2-Positive Cancer Cells , 2014, Molecular pharmaceutics.

[187]  Jinming Gao,et al.  Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells. , 2011, Angewandte Chemie.

[188]  T. Iwamoto.  Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs. , 2013, Biological & pharmaceutical bulletin.

[189]  R. Jain,et al.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.

[190]  Kit S Lam,et al.  Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. , 2011, Biomaterials.

[191]  Mauro Ferrari,et al.  Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.

[192]  Samuel Zalipsky,et al.  Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. , 2004, Advanced drug delivery reviews.

[193]  J. Kong,et al.  pH and reduction dual-sensitive copolymeric micelles for intracellular doxorubicin delivery. , 2011, Biomacromolecules.

[194]  T. Allen.  Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.

[195]  Zhuxian Zhou,et al.  Synthesis of an esterase‐sensitive degradable polyester as facile drug carrier for cancer therapy , 2016 .

[196]  Daniel S. Kohane,et al.  Photoswitchable nanoparticles for in vivo cancer chemotherapy , 2013, Proceedings of the National Academy of Sciences.

[197]  Dai Fukumura,et al.  A nanoparticle size series for in vivo fluorescence imaging. , 2010, Angewandte Chemie.

[198]  Leaf Huang,et al.  Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[199]  Chao Yang,et al.  In Situ Formation of Nanofibers from Purpurin18‐Peptide Conjugates and the Assembly Induced Retention Effect in Tumor Sites , 2015, Advanced materials.

[200]  Yolonda L Colson,et al.  Biologically Responsive Polymeric Nanoparticles for Drug Delivery , 2012, Advanced materials.

[201]  Xuesi Chen,et al.  pH-Triggered charge-reversal polypeptide nanoparticles for cisplatin delivery: preparation and in vitro evaluation. , 2013, Biomacromolecules.

[202]  Mark E. Davis,et al.  Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles , 2009, Proceedings of the National Academy of Sciences.

[203]  Dong Liang,et al.  Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles , 2009, Nanotechnology.

[204]  Shaoyi Jiang,et al.  Ultralow‐Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications , 2010, Advanced materials.

[205]  David Putnam,et al.  Polymers for gene delivery across length scales , 2006, Nature materials.

[206]  Gerd Ulrich Nienhaus,et al.  New views on cellular uptake and trafficking of manufactured nanoparticles , 2013, Journal of The Royal Society Interface.

[207]  Erin Lavik,et al.  The role of nanomaterials in translational medicine. , 2011, ACS nano.

[208]  S. Choi,et al.  Polymer brush-stabilized polyplex for a siRNA carrier with long circulatory half-life. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[209]  E. Forssen.  The design and development of DaunoXome® for solid tumor targeting in vivo , 1997 .

[210]  Michael S. Strano,et al.  Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. , 2009, ACS nano.

[211]  William R. Dichtel,et al.  Enzyme-responsive snap-top covered silica nanocontainers. , 2008, Journal of the American Chemical Society.

[212]  Jin-Zhi Du,et al.  Facile Generation of Tumor-pH-Labile Linkage-Bridged Block Copolymers for Chemotherapeutic Delivery. , 2016, Angewandte Chemie.

[213]  J. Kopeček,et al.  Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[214]  Eddie Reed,et al.  Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review). , 2004, Oncology reports.

[215]  I. Tannock,et al.  Drug penetration in solid tumours , 2006, Nature Reviews Cancer.

[216]  Jaroslav Pelisek,et al.  Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[217]  A. Fyles,et al.  The relationship between elevated interstitial fluid pressure and blood flow in tumors: a bioengineering analysis. , 1999, International journal of radiation oncology, biology, physics.

[218]  R. Jain,et al.  Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. , 2000, Cancer research.

[219]  Triantafyllos Stylianopoulos,et al.  Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. , 2011, Annual review of chemical and biomolecular engineering.

[220]  Qiao Jiang,et al.  Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. , 2010, ACS nano.

[221]  Sang Cheon Lee,et al.  Controlled release of guest molecules from mesoporous silica particles based on a pH-responsive polypseudorotaxane motif. , 2007, Angewandte Chemie.

[222]  Zhuxian Zhou,et al.  A linear polyethylenimine (LPEI) drug conjugate with reversible charge to overcome multidrug resistance in cancer cells , 2015 .

[223]  Jan E Schnitzer,et al.  Overcoming in vivo barriers to targeted nanodelivery. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[224]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[225]  T. Park,et al.  Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide. , 2003, Bioconjugate chemistry.

[226]  Shaoyi Jiang,et al.  Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity. , 2011, Nature chemistry.

[227]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.

[228]  W. Hennink,et al.  Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles. , 2015, Biomaterials.

[229]  Jong-Mok Kim,et al.  Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate. , 2009, Bioconjugate chemistry.

[230]  Wantong Song,et al.  Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery. , 2014, Molecular pharmaceutics.

[231]  P. Ferruti,et al.  New poly(amidoamine)s containing disulfide linkages in their main chain , 2005 .

[232]  K. Kataoka,et al.  Ion pair-driven heterodimeric capsule based on boronate esterification: construction and the dynamic behavior. , 2007, Journal of the American Chemical Society.

[233]  Mauro Giacca,et al.  Virus-mediated gene delivery for human gene therapy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[234]  Qiang Zhang,et al.  Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy. , 2014, Biomaterials.

[235]  T. Ji,et al.  Peptide Assembly Integration of Fibroblast‐Targeting and Cell‐Penetration Features for Enhanced Antitumor Drug Delivery , 2015, Advanced materials.

[236]  Vincent M. Rotello,et al.  Tuning Payload Delivery in Tumour Cylindroids using Gold Nanoparticles , 2010, Nature nanotechnology.

[237]  Liangzhu Feng,et al.  Hyaluronidase To Enhance Nanoparticle-Based Photodynamic Tumor Therapy. , 2016, Nano letters.

[238]  M. Milowsky,et al.  The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors. , 2016, ACS nano.

[239]  Bo Zhang,et al.  Acid-active cell-penetrating peptides for in vivo tumor-targeted drug delivery. , 2013, Journal of the American Chemical Society.

[240]  Hillary Holback,et al.  Intratumoral Drug Delivery with Nanoparticulate Carriers , 2011, Pharmaceutical Research.

[241]  M. Radosz,et al.  Multilayered Nanoparticles for Controlled Release of Paclitaxel Formed by Near-Critical Micellization of Triblock Copolymers , 2012 .

[242]  R. Bellamkonda,et al.  Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma , 2007 .

[243]  Adah Almutairi,et al.  Photochemical mechanisms of light-triggered release from nanocarriers. , 2012, Advanced drug delivery reviews.

[244]  J. Weinstein,et al.  Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. , 1992, Cancer research.

[245]  Jun Wang,et al.  Surface Charge Switchable Nanoparticles Based on Zwitterionic Polymer for Enhanced Drug Delivery to Tumor , 2012, Advanced materials.

[246]  Jianbin Tang,et al.  Fusogenic Reactive Oxygen Species Triggered Charge‐Reversal Vector for Effective Gene Delivery , 2016, Advanced materials.

[247]  Tao Wu,et al.  Tunable redox-responsive hybrid nanogated ensembles. , 2008, Journal of the American Chemical Society.

[248]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[249]  Jingyu Wan,et al.  A Novel Strategy through Combining iRGD Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration. , 2015, ACS applied materials & interfaces.

[250]  K. Ulbrich,et al.  Polymeric anticancer drugs with pH-controlled activation. , 2004, Advanced drug delivery reviews.

[251]  R. Jain,et al.  Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.

[252]  Maohong Fan,et al.  Charge‐Reversal Drug Conjugate for Targeted Cancer Cell Nuclear Drug Delivery , 2009 .

[253]  Youqing Shen,et al.  Challenges in design of translational nanocarriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[254]  Zhen Gu,et al.  Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery. , 2014, Angewandte Chemie.

[255]  Y. Barenholz.  Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[256]  Alexander V Kabanov,et al.  Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[257]  S. Ganta,et al.  A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[258]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[259]  Yuichi Yamasaki,et al.  PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors. , 2008, Journal of the American Chemical Society.

[260]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[261]  Chun Xing Li.  Poly(L-glutamic acid)--anticancer drug conjugates. , 2002, Advanced drug delivery reviews.

[262]  Junfeng Zhang,et al.  A pH/enzyme-responsive tumor-specific delivery system for doxorubicin. , 2010, Biomaterials.

[263]  J. Reynolds,et al.  Nanomedicine applied to translational oncology: A future perspective on cancer treatment. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[264]  S. Schwarze,et al.  In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.

[265]  Kazunori Kataoka,et al.  Progress of drug-loaded polymeric micelles into clinical studies. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[266]  Hua Lu,et al.  Light-responsive helical polypeptides capable of reducing toxicity and unpacking DNA: toward nonviral gene delivery. , 2013, Angewandte Chemie.

[267]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[268]  Tuo Wei,et al.  Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. , 2012, ACS nano.

[269]  R. Tsien,et al.  Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases , 2010, Proceedings of the National Academy of Sciences.

[270]  Tao Wang,et al.  Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies. , 2012, International journal of pharmaceutics.

[271]  J. Davies,et al.  Cystic fibrosis gene therapy: a mutation-independent treatment , 2016, Current opinion in pulmonary medicine.

[272]  R. Jain.  Delivery of molecular and cellular medicine to solid tumors. , 2001, Advanced drug delivery reviews.

[273]  Victor S-Y Lin,et al.  A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.

[274]  A. Kabanov,et al.  Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[275]  Lothar Lilge,et al.  The Distribution of the Anticancer Drug Doxorubicin in Relation to Blood Vessels in Solid Tumors , 2005, Clinical Cancer Research.

[276]  M. Dewhirst,et al.  Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. , 2012, Cancer research.

[277]  Young Jik Kwon,et al.  Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications. , 2012, Advanced drug delivery reviews.